| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |